The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Edwards, N. B.
* Articles by Rosenthal, T. L.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Edwards, N. B.
* Articles by Rosenthal, T. L.

Am J Psychiatry 1989; 146:373-376
Copyright © 1989 by American Psychiatric Association


REGULAR ARTICLES

Doxepin as an adjunct to smoking cessation: a double-blind pilot study

NB Edwards, JK Murphy, AD Downs, BJ Ackerman and TL Rosenthal
Department of Psychiatry, University of Tennessee College of Medicine, Memphis 38105.

In a double-blind study, 19 adults received bedtime doses of either 150 mg of doxepin hydrochloride (N = 9) or placebo (N = 10). After 3 weeks the subjects were instructed to stop smoking and continue taking medication for 4 additional weeks. Cessation was reported by all nine doxepin subjects 1 week after cessation and by seven doxepin subjects 9 weeks after cessation. One placebo subject reported cessation. Cotinine assays generally confirmed cessation but were subject to interpretation. Doxepin assays suggested that the precessation level was associated with cessation. Further studies with larger samples and extended follow-up are needed to determine the reliability of these results.


This article has been cited by other articles:


Home page
Anesth. Analg.Home page
P. Gerner, V. Srinivasa, A. M. Zizza, Z.-Y. Zhuang, S. Luo, D. Zurakowski, S. Eappen, and G. Wang
Doxepin by Topical Application and Intrathecal Route in Rats
Anesth. Analg., January 1, 2006; 102(1): 283 - 287.
[Abstract] [Full Text] [PDF]


Home page
CA Cancer J ClinHome page
J. E. Henningfield, R. V. Fant, A. R. Buchhalter, and M. L. Stitzer
Pharmacotherapy for Nicotine Dependence
CA Cancer J Clin, September 1, 2005; 55(5): 281 - 299.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
C. L. da Costa, R. N. Younes, and M. T. C. Lourenco
Stopping Smoking* : A Prospective, Randomized, Double-Blind Study Comparing Nortriptyline to Placebo
Chest, August 1, 2002; 122(2): 403 - 408.
[Abstract] [Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
S. M. Hall, V. I. Reus, R. F. Munoz, K. L. Sees, G. Humfleet, D. T. Hartz, S. Frederick, and E. Triffleman
Nortriptyline and Cognitive-Behavioral Therapy in the Treatment of Cigarette Smoking
Arch Gen Psychiatry, August 1, 1998; 55(8): 683 - 690.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
R. D. Hurt, D. P.L. Sachs, E. D. Glover, K. P. Offord, J. A. Johnston, L. C. Dale, M. A. Khayrallah, D. R. Schroeder, P. N. Glover, C. R. Sullivan, et al.
A Comparison of Sustained-Release Bupropion and Placebo for Smoking Cessation
N. Engl. J. Med., October 23, 1997; 337(17): 1195 - 1202.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
N. L. Benowitz
Treating Tobacco Addiction -- Nicotine or No Nicotine?
N. Engl. J. Med., October 23, 1997; 337(17): 1229 - 1231.
[Full Text]




Get information about faster international access.

Privacy Policy

Copyright © 1989 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org